焦作萬方(000612.SZ):公司由無實際控制人變更爲實際控制人爲鈄正剛
格隆匯3月19日丨焦作萬方(000612.SZ)公佈,目前,公司董事會由9名董事構成,其中5名董事由浙江安晟及寧波中曼提名,並經公司股東大會選舉通過,佔焦作萬方董事會成員的過半數。浙江安晟及寧波中曼合計持有焦作萬方23,017.87萬股股份,佔公司總股本的19.31%,浙江安晟及寧波中曼系鈄正剛先生實際控制企業。根據《公司法》《上市公司收購管理辦法》等相關法律法規的規定,結合公司目前股東持股及董事會成員發生的變更情況,公司控制權變更已完成,公司由無實際控制人變更爲實際控制人爲鈄正剛先生。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.